Variations in cancer care for adolescents and young adults (AYAs) with ductal carcinoma in situ
Author:
Affiliation:
1. John Wayne Cancer Institute at Providence Saint John's Health Center; Santa Monica CA USA
2. David Geffen School of Medicine; UCLA; Los Angeles CA USA
Publisher
Hindawi Limited
Subject
Oncology,Surgery,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/tbj.12999/fullpdf
Reference18 articles.
1. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium;Allison;Cancer,2015
2. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study;Collins;Cancer,2005
3. Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast and bowel project B-24 randomised controlled trial;Fisher;Lancet,1999
4. Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24;Allred;J Clin Oncol,2012
5. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ;Yen;JCO,2007
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Utilisation of endocrine therapy for cancer in Indigenous peoples: a systematic review and meta-analysis;BMC Cancer;2024-07-22
2. Second Primary Breast Cancer in Young Breast Cancer Survivors;JAMA Oncology;2024-06-01
3. A juvenile female with ductal carcinoma In situ arising from a fibroadenoma;Journal of Cancer Research and Practice;2023
4. Ductal carcinoma in situ in patients younger than 30 years: differences in adjuvant endocrine therapy and outcomes;Breast Cancer Research and Treatment;2020-11-12
5. Disparities in Risk Reduction Therapy Recommendations for Young Women With Lobular Carcinoma In-Situ;Clinical Breast Cancer;2020-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3